FDA Addresses Potential Shortage of Newborn Nutritional Products

Why it matters locally: A potential shortage of neonatal nutritional products could impact Oregon's premature and critically ill newborns, requiring hospitals across the state to manage existing supplies carefully.

---

WASHINGTON – The U.S. Food and Drug Administration (FDA) today initiated steps to prevent a potential shortage of neonatal starter parenteral nutrition (PN) products. This action aligns with the administration's stated commitment to protecting vulnerable patients and ensuring access to essential medical supplies. Neonatal starter PN provides critical nutrition for premature and critically ill newborns who cannot consume food orally. A disruption in the supply of these products could impact the care of these infants. The FDA did not specify the exact nature of the potential supply gap but indicated its actions directly address this concern. The agency previously stated its intent to protect vulnerable patients and maintain access to critical medical products.